These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 26639394)

  • 1. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism.
    Wan X; Xu C; Lin Y; Lu C; Li D; Sang J; He H; Liu X; Li Y; Yu C
    J Hepatol; 2016 Apr; 64(4):925-32. PubMed ID: 26639394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
    Sui YH; Luo WJ; Xu QY; Hua J
    World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
    Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
    J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
    Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction.
    Xing JH; Li R; Gao YQ; Wang MY; Liu YZ; Hong J; Dong JZ; Gu HP; Li L
    Life Sci; 2019 Dec; 239():116882. PubMed ID: 31705915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bee's honey attenuates non-alcoholic steatohepatitis-induced hepatic injury through the regulation of thioredoxin-interacting protein-NLRP3 inflammasome pathway.
    Xiao J; Liu Y; Xing F; Leung TM; Liong EC; Tipoe GL
    Eur J Nutr; 2016 Jun; 55(4):1465-77. PubMed ID: 26133299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide protects non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in a mouse model induced by high-fat diet.
    Zhu W; Feng PP; He K; Li SW; Gong JP
    Biochem Biophys Res Commun; 2018 Oct; 505(2):523-529. PubMed ID: 30269815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1.
    Xiang W; Yang Y; Weng L; Ye Z; Ding P; Li H; Sun J; Zeng C
    Int Immunopharmacol; 2023 May; 118():110085. PubMed ID: 37018978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.
    Yang G; Lee HE; Lee JY
    Sci Rep; 2016 Apr; 6():24399. PubMed ID: 27075683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.
    Hu Y; Mao K; Zeng Y; Chen S; Tao Z; Yang C; Sun S; Wu X; Meng G; Sun B
    J Immunol; 2010 Dec; 185(12):7699-705. PubMed ID: 21048113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.
    Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS
    Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Glucose-Aggravated Hepatic Insulin Resistance: Role of the NLRP3 Inflammasome in Kupffer Cells.
    Zheng T; Wang Q; Dong Y; Ma W; Zhang Y; Zhao Y; Bian F; Chen L
    Obesity (Silver Spring); 2020 Jul; 28(7):1270-1282. PubMed ID: 32538511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.
    Dai Y; Cao Y; Zhang Z; Vallurupalli S; Mehta JL
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):19-27. PubMed ID: 28084571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock.
    Gong Z; Zhou J; Li H; Gao Y; Xu C; Zhao S; Chen Y; Cai W; Wu J
    Mol Nutr Food Res; 2015 Nov; 59(11):2132-42. PubMed ID: 26250869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome.
    Kim DH; Kim SM; Lee B; Lee EK; Chung KW; Moon KM; An HJ; Kim KM; Yu BP; Chung HY
    J Nutr Biochem; 2017 Jul; 45():104-114. PubMed ID: 28499186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
    Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
    Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress.
    Zilu S; Qian H; Haibin W; Chenxu G; Deshuai L; Qiang L; Linfeng H; Jun T; Minxuan X
    Aging (Albany NY); 2019 Dec; 11(24):12177-12201. PubMed ID: 31841118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.
    Yu X; Hao M; Liu Y; Ma X; Lin W; Xu Q; Zhou H; Shao N; Kuang H
    Eur J Pharmacol; 2019 Dec; 864():172715. PubMed ID: 31593687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement.
    Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q
    Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.